Hydroxyzine Orifarm

Hydroxyzine hydrochloride, the active ingredient in Hydroxyzine Orifarm, is a first‑generation antihistamine presented as an oral formulation for systemic use. It treats allergic skin conditions such as dermatitis and urticaria, relieves pruritus, provides short‑term anxiety relief, and offers sedation useful before procedures or for nausea control. The product is manufactured for the EU market and meets European regulatory standards.

GNH USA supplies Hydroxyzine Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydroxyzine Orifarm, a first‑generation antihistamine, alleviates symptoms across several allergic and anxiety‑related conditions.

- Allergic skin conditions (e.g., dermatitis, urticaria): reduces itching and rash. - Pruritus: relieves intense itching associated with dermatologic disorders. - Anxiety: provides short‑term anxiolytic effect for mild anxiety. - Sedation: induces calming effect useful for pre‑procedural preparation. - Nausea and vomiting: helps control symptoms in various clinical settings.

Hydroxyzine Orifarm may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Dry mouth: reduced salivation leading to oral discomfort. - Dizziness: sensation of light‑headedness or imbalance. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm that may require medical attention. - Severe hypotension: marked drop in blood pressure causing faintness. - Anaphylactic reaction: severe allergic response with potential airway compromise.

When prescribing Hydroxyzine Orifarm, clinicians should consider several precautionary measures to ensure patient safety.

- Hepatic function: evaluate liver status before initiating therapy. - Elderly patients: use lower doses and monitor for increased sedation. - Driving and machinery: advise patients to avoid operating vehicles until they know how the drug affects them. - QT interval: monitor patients with known cardiac conduction abnormalities. - Concomitant CNS depressants: avoid or use with caution due to additive sedation. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Hydroxyzine Orifarm can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Central nervous system depressants (e.g., alcohol, benzodiazepines): may cause excessive sedation. - Monoamine oxidase inhibitors: risk of severe hypotension and anticholinergic effects. - QT‑prolonging agents (e.g., certain antiarrhythmics): increase risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: hydroxyzine may enhance blood pressure‑lowering effects. - Digoxin: potential increase in serum digoxin concentrations. - Theophylline: may reduce theophylline clearance, leading to toxicity.